Exposure to Radioactive Iodine-131 for Scintigraphy or Therapy Does Not Preclude Pregnancy in Thyroid Cancer Patients

Journal of Nuclear Medicine

Volumn 37, Issue 4-6, 1996, Pages 606-612

  Schlumberger, Martin ^a   De Vathaire, Florent ^a   Ceccarelli, Claudia ^a   Delisle, Marie Joëlle ^a   Francese, Cecilia ^a   Couette, Jean Etienne ^a   Pinchera, Aldo ^a   Parmentier, Claude ^a  

^a Department of Nuclear Medicine ^*

Author keywords

Iodine 131; Pregnancy outcome

Indexed keywords

DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; FEMALE; HUMAN; INDUCED ABORTION; LOW BIRTH WEIGHT; MULTICENTER STUDY; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL EXPOSURE; RADIATION DOSE; RADIATION INJURY; RISK FACTOR; SCINTISCANNING; SPONTANEOUS ABORTION; STATISTICS; THYROID DISEASE; THYROID TUMOR;

ABNORMALITIES, RADIATION-INDUCED; ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADULT; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; IODINE RADIOISOTOPES; NEOPLASMS, RADIATION-INDUCED; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; RADIATION DOSAGE; RISK FACTORS; THYROID DISEASES; THYROID NEOPLASMS;

EID: 0030119606     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dunn JT. Choice of therapy in young adults with hyperthyroidism of Graves' disease. Ann Intern Med 1984;100:891-893.
2. Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med 1982;23:561-568.
3. MIRD. MIRD primer for absorbed dose calculations. Reston, VA: Society of Nuclear Medicine: 1988.
4. Izembart M, Chavaudra J, Aubert B, Vallée G. Retrospective evaluation of the dose received by the ovary after radioactive iodine therapy for thyroid cancer. Eur J Nucl Med 1992;19:243-247.
5. Schull WJ, Otake M, Neel JV. Genetic effects of the atomic bombs: a re-appraisal. Science 1981;213:1220-1227.
6. Otake M, Schull WJ, Neel JV Congenital malformations, stillbirths and early mortality among the children of atomic bomb survivors: a re-analysis. Radiat Res 1990;122:1-11.
7. Yoshimoto Y, Neel JV, Schull WJ, et al. Malignant tumors during the first two decades of life in the offspring of atomic bomb survivors. Am J Hum Genet 1990;46:1041-1052.
8. Mulvihill JJ, Myers MH, Connelly RR, et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987;2:813-817.
9. Hawkins MM, Draper GJ, Smith RA. Cancer among 1348 offspring of survivors of childhood cancer. Int J Cancer 1989;43:975-978.
10. Hawkins MM. Is there evidence of a therapy related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst 1991;83:1643-1650.
11. Gardner MJ, Snee MP, Hall AJ, et al. Results of a case-control study of leukemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. Br Med J 1990;300:423-429.
12. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
13. Simpson WJ, Panzarella T, Carruthers JS, et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiation Oncol Biol Phys 1988;14:1063-1075.
14. Schlumberger M, De Vathaire F, Travagli JP, et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 1987;65: 1088-1094.
15. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clinics of North America 1990;19:545-576.
16. Samaan NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985;60:376-380.
17. Schlumberger M, Tubiana M, De Vathaire F, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986;63:960-967.
18. Hayek A, Chapman EM, Crawford JD. Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. N Engl J Med 1970;283: 949-953.
19. Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine for hyperthyroidism. N Engl J Med 1975;292:167-171
20. Freitas JE, Swanson DP, Gross MD, Sisson JC. Iodine-131: optimal therapy for hyperthyroidism in children and adolescents? J Nucl Med 1979;20:847-850.
21. Winship T, Rosvoll RV. Thyroid carcinoma in childhood. Final report on a 20-yr study. Proc Natl Cancer Conf 1970;6:677-681.
22. Einhorn J, Hullen M, Lindsten J, et al. Clinical and cytogenetic investigation in children of parents treated with radioiodine. Acta Radiol 1972;11:193-208.
23. 131I for thyroid cancer. J Nucl Med 1976;17:460-464.
24. Edmonds CJ, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986;59:45-51.
25. Emrich D, Creutzig H. Benefits and risks of radioactive iodine therapy in differentiated thyroid carcinoma. Prog Surg 1988;19:133-146.
26. Casara D, Rabello D, Saladini G, et al. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations. Eur J Nucl Med 1993;20:192-194.
27. Dottormi ME, Lomuscio G, Mazzucchelli L, et al. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995;36:21-27.
28. Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28:1888-1891.
29. Leroy B, Lefort F. A propos du poids et de la taille des nouveau-nés à la naissance. Rev Fr Gynecol 1971;66:391-396.
30. World Health Organization. The international classification of diseases. 9th Rev. vol. I. Diseases tabular list. Geneva; World Health Organization: 1977.
31. Preston DL, Lubin JH, Pierce PA. Epicure user's guide (draft). Seattle; Hirosoft Inter Corp: 1990.
32. Preston DL. In: Blot WJ, Hirayama T, Hoel DG, eds. Statistical Methods in Cancer Epidemiology. Hiroshima, RERF: 1985;109-128.
33. Breslow NE. Day NE. The design and analysis of cohort studies. IARC, Scientific Publication 82, Lyon, France, 1987.
34. Coleman MP, Hermon C, Douglas A. Person-years (PYRS). A fortran program for cohort study analysis. IARC Internal Report 89, Lyon, France, 1989.
35. Muir C, Waterhouse J, Mack T, Powell J. Cancer incidence in five continents IARC Scientific Publication 88. Lyon, France, 1987.
36. François P, Beurtheret C, Dutreix A. Calculation of the dose delivered to organs outside the radiation beams. Medical Physics 1988;15:879-883.
37. Kereiakes JG, Rosenstein M. Handbook of radiation doses in nuclear medicine and diagnostic x-ray. Boca Raton, Florida; CRC Press: 1988.
38. Bureau International du Travail. Classification internationale type des professions. Genève: Bureau International du Travail; 1985.
39. United Nations Scientific Committee on the effects of atomic radiation: sources, effects, and risks of ionizing radiation. Publ. no. E88 1X 7 New-York; United Nations: 1988.
40. Sever LE, Gilbert ES, Hessol NA, Mc Intyre JM. A ease-control study of congenital malformations and occupational exposure to low-level ionizing radiation. Am J Epidemiol 1988,127:226-242.